X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (525) 525
inhaled iloprost (433) 433
hypertension, pulmonary - drug therapy (362) 362
pulmonary hypertension (349) 349
index medicus (327) 327
inhaled nitric-oxide (220) 220
respiratory system (213) 213
female (206) 206
hypertension, pulmonary - physiopathology (204) 204
male (200) 200
cardiac & cardiovascular systems (196) 196
pulmonary arterial hypertension (189) 189
double-blind (182) 182
prostacyclin (175) 175
therapy (171) 171
sildenafil (169) 169
arterial-hypertension (168) 168
iloprost (142) 142
bosentan (135) 135
treatment outcome (133) 133
vasodilator agents - therapeutic use (133) 133
middle aged (131) 131
adult (130) 130
oral sildenafil (130) 130
antihypertensive agents - therapeutic use (129) 129
continuous intravenous epoprostenol (127) 127
hypertension (126) 126
survival (124) 124
administration, inhalation (114) 114
sildenafil citrate (109) 109
medicine, general & internal (106) 106
pharmacology & pharmacy (104) 104
drug therapy, combination (102) 102
care and treatment (101) 101
prostacyclin analog (101) 101
vasodilator agents - administration & dosage (99) 99
placebo-controlled trial (97) 97
epoprostenol (93) 93
hypertension, pulmonary - etiology (93) 93
animals (91) 91
hypertension, pulmonary - diagnosis (89) 89
drug therapy (86) 86
combination therapy (84) 84
endothelin receptor antagonists (82) 82
calcium-channel blockers (81) 81
epoprostenol - therapeutic use (79) 79
treprostinil (77) 77
iloprost - administration & dosage (76) 76
long-term treatment (74) 74
hypertension, pulmonary - therapy (73) 73
piperazines - therapeutic use (72) 72
epoprostenol - analogs & derivatives (70) 70
nitric oxide (69) 69
aged (67) 67
pediatrics (67) 67
antihypertensive agents - administration & dosage (65) 65
aerosolized iloprost (64) 64
bosentan therapy (63) 63
critical care medicine (61) 61
pulmonary arteries (61) 61
child (59) 59
controlled-trial (59) 59
hemodynamics (59) 59
research (59) 59
epoprostenol - administration & dosage (57) 57
diagnosis (56) 56
abridged index medicus (54) 54
mortality (54) 54
familial primary pulmonary hypertension (52) 52
phosphodiesterase inhibitors - therapeutic use (52) 52
surgery (52) 52
disease (51) 51
congenital heart-disease (50) 50
endothelin-receptor antagonist (50) 50
purines (50) 50
sulfones (50) 50
iloprost - therapeutic use (49) 49
prognosis (48) 48
nitric-oxide (47) 47
adolescent (46) 46
endothelin receptor antagonist (46) 46
children (45) 45
intravenous epoprostenol (44) 44
transplantation (44) 44
hemodynamics - drug effects (43) 43
medicine & public health (42) 42
prostaglandins - therapeutic use (42) 42
risk factors (42) 42
dosage and administration (41) 41
randomized controlled-trial (41) 41
respiratory-distress-syndrome (41) 41
vascular resistance - drug effects (41) 41
hypertension, pulmonary - complications (40) 40
infant, newborn (40) 40
vasodilators (40) 40
endothelin (39) 39
hypertension, pulmonary - mortality (39) 39
prostanoids (39) 39
cardiology (38) 38
randomized controlled trials as topic (38) 38
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (658) 658
German (40) 40
French (20) 20
Spanish (14) 14
Turkish (7) 7
Russian (5) 5
Portuguese (2) 2
Japanese (1) 1
Korean (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Endodontics, ISSN 0099-2399, 2014, Volume 40, Issue 11, pp. 1784 - 1790
Journal Article
Journal Article
European Respiratory Journal, ISSN 0903-1936, 07/2009, Volume 34, Issue 1, pp. 132 - 137
Journal Article
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, ISSN 0277-0008, 09/2016, Volume 36, Issue 9, pp. e142 - e147
Journal Article
American Journal of Physiology - Lung Cellular and Molecular Physiology, ISSN 1040-0605, 10/2018, Volume 315, Issue 4, pp. L535 - L544
Cyclooxygenase-2 (COX-2/PTGS2) mediates hyperoxia-induced impairment of lung development in newborn animals and is increased in the lungs of human infants with... 
infant, newborn | Infant | Newborn | prostacyclin | lung development | oxidative stress | INHALED ILOPROST | PHYSIOLOGY | AIRWAY INFLAMMATION | PRETERM INFANTS | newborn | ALVEOLAR DEVELOPMENT | infant | PRIMARY PULMONARY-HYPERTENSION | NEONATAL-RATS | BRONCHOPULMONARY DYSPLASIA | TUMOR-NECROSIS-FACTOR | RESPIRATORY SYSTEM | PROSTACYCLIN ANALOG | ARTERIAL-HYPERTENSION
Journal Article
PLoS ONE, ISSN 1932-6203, 12/2012, Volume 7, Issue 12, p. e52248
Journal Article
Chest, ISSN 0012-3692, 2013, Volume 144, Issue 1, pp. 55 - 62
Objective We hypothesized that nebulized iloprost would improve ventilation-perfusion matching in patients with pulmonary hypertension and ARDS as reflected by... 
Pulmonary/Respiratory | MULTICENTER CLINICAL-TRIAL | THERAPY | RESPIRATORY SYSTEM | DOUBLE-BLIND | AEROSOLIZED PROSTACYCLIN | ACUTE LUNG INJURY | VASCULAR-RESISTANCE | INHALED NITRIC-OXIDE | PROSTAGLANDIN E | TLC C-53 | RESPIRATORY-DISTRESS-SYNDROME | CRITICAL CARE MEDICINE | Respiratory Distress Syndrome, Adult - physiopathology | Iloprost - pharmacology | Vasodilator Agents - therapeutic use | Humans | Middle Aged | Hypertension, Pulmonary - physiopathology | Male | Hemodynamics - physiology | Dose-Response Relationship, Drug | Respiratory Mechanics - drug effects | Pulmonary Gas Exchange - drug effects | Adult | Female | Hypertension, Pulmonary - drug therapy | Respiratory Mechanics - physiology | Iloprost - administration & dosage | Vasodilator Agents - pharmacology | Comorbidity | Administration, Inhalation | Treatment Outcome | Hypertension, Pulmonary - epidemiology | Respiratory Distress Syndrome, Adult - drug therapy | Pulmonary Gas Exchange - physiology | Iloprost - therapeutic use | Aged | Hemodynamics - drug effects | Respiratory Distress Syndrome, Adult - epidemiology | Vasodilator Agents - administration & dosage | Acute respiratory distress syndrome | Iloprost | Care and treatment | Patient outcomes | Dosage and administration | Research | Hemodynamics | Pulmonary hypertension | Pulmonary gas exchange
Journal Article
Respiratory Medicine, ISSN 0954-6111, 2010, Volume 104, Issue 5, pp. 731 - 740
Journal Article
by Li, JH and Zhang, HD and Wang, ZZ and Lu, QQ and Li, D and Lian, TY and Lv, ZC and Jiang, X and Wu, Y and Ye, J and Zhao, SH and Yang, ZW
FRONTIERS IN PHARMACOLOGY, ISSN 1663-9812, 01/2019, Volume 9, p. 1550
Background: Right ventricle (RV) function is among the most important prognostic factors for pulmonary arterial hypertension (PAH) patients. Inhaled iloprost,... 
INHALED ILOPROST | iloprost | pulmonary artery hypertension | ANALOG | PROSTACYCLIN | HEART | THERAPY | right ventricle | PROSTAGLANDINS | ENHANCEMENT | PHARMACOLOGY & PHARMACY | pulmonary vascular resistance | cardiac magnetic resonance | Usage | Care and treatment | Iloprost | Prognosis | Magnetic resonance imaging | Dosage and administration | Pulmonary hypertension
Journal Article
Canadian Journal of Anesthesia/Journal canadien d'anesthésie, ISSN 0832-610X, 8/2019, Volume 66, Issue 8, pp. 907 - 920
Perioperative right ventricular (RV) failure due to pressure overload from pulmonary hypertension (PH) worsens postoperative outcomes after cardiac surgery.... 
Pediatrics | Pain Medicine | Pneumology/Respiratory System | Medicine & Public Health | Intensive / Critical Care Medicine | Anesthesiology | Cardiology | RIGHT-VENTRICULAR FAILURE | PULMONARY-HYPERTENSION | CONTRACTILITY | CIRCULATION | EPOPROSTENOL | SURGERY PATIENTS | PROSTACYCLIN | HEART-FAILURE | ANESTHESIOLOGY | CARDIOPULMONARY BYPASS | INHALED NITRIC-OXIDE
Journal Article
Journal Article
Journal Article